Abstract
Post-orgasmic illness syndrome (POIS) is a rare and under-recognized condition characterized by the onset of distressing somatic, cognitive, and affective symptoms shortly after ejaculation, with spontaneous resolution within hours to days. Since its description by Waldinger, POIS has remained diagnostically challenging, particularly in psychiatric settings due to its close phenomenological overlap with anxiety and panic disorders. 1
We report a clinically instructive case highlighting the diagnostic complexity of POIS in a patient with remitted panic disorder and the importance of temporal symptom analysis in psychosexual practice. A 32-year-old married Indian male, previously diagnosed with panic disorder, had achieved full remission of spontaneous panic attacks on escitalopram 20 mg for more than 18 months. Despite this, he developed reproducible post-ejaculatory symptoms over two years, occurring within minutes after ejaculation during intercourse or masturbation. Symptoms included profuse sweating, acute anxiety, tremulousness, burning sensations over the body, palpitations, dyspnea, dysphoria, and cognitive dulling described as “brain fog.” These episodes peaked within an hour and persisted for 12–24 hours, resolving spontaneously.
The consistent temporal association with ejaculation, reproducibility across episodes, and absence of anxiety symptoms outside sexual activity differentiated this presentation from panic disorder relapse. Extensive medical, neurological, endocrine, and urological evaluations were unremarkable. The clinical picture fulfilled Waldinger’s diagnostic criteria for POIS, specifically the autonomic/anxiety subtype. 1 Misattribution to anxiety relapse had contributed to significant sexual avoidance, reduced intimacy, and marital distress.
In the Indian sociocultural context, psychosexual symptoms are often associated with stigma and delayed disclosure. Solanki and Agarwal have highlighted that psychosexual disorders remain under-reported despite their substantial psychosocial impact. 2 In this case, cultural beliefs regarding sexuality and ejaculation amplified shame and avoidance, reinforcing the importance of sensitive, non-judgmental assessment.
Management involved a multimodal approach targeting autonomic, psychological, and relational factors. Escitalopram was continued for baseline anxiety control. Pre-intercourse propranolol and low-dose clonazepam reduced autonomic arousal, while the addition of a second-generation antihistamine resulted in marked improvement of burning sensations and overall symptom severity, supporting a possible hypersensitivity mechanism described in previous reports.3–5 Psychoeducation reframing POIS as a neuro-immunological condition reduced guilt and anticipatory anxiety. Progressive muscle relaxation and couples counseling further facilitated symptom control and restoration of intimacy.
At three months, symptom severity had reduced by more than 70% with significant reduction in avoidance behavior. At six months, the patient reported near-complete symptom resolution and restoration of marital and sexual functioning.
This correspondence emphasizes the need to consider POIS in the differential diagnosis of post-ejaculatory anxiety symptoms, especially in patients with a history of panic disorder. Failure to recognize this entity may lead to unnecessary medication escalation and prolonged distress. Increased awareness among psychiatrists and psychosexual health professionals can facilitate timely diagnosis and targeted multimodal management, resulting in meaningful functional recovery.
Footnotes
Acknowledgements
The authors acknowledge the support of Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, for providing the clinical infrastructure for patient care and follow-up. We sincerely thank the patient for providing informed consent and for permitting the use of their clinical information for academic and publication purposes.
No professional writing or editorial assistance was used in the preparation of this manuscript.
Anonymity Statement
All identifying patient information has been removed to ensure anonymity and confidentiality in accordance with journal and ethical guidelines.
Authors’ Contribution
Dr Megha CN: Conceptualization, patient evaluation, follow-up, data acquisition, manuscript drafting, literature integration.
Dr Kiran Kumar K: Clinical supervision, diagnostic validation, manuscript review, critical intellectual revision, final approval.
Dr Sujay Segu N: Patient management, clinical documentation, literature review, manuscript assistance.
Data Availability Statement
The data supporting the findings of this study are available from the corresponding author upon reasonable request. Patient confidentiality and privacy restrictions apply.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical Approval and Informed Consent
Written informed consent was obtained from the patient for the publication of this case report and accompanying clinical information. The study was conducted in accordance with institutional ethical standards and the Declaration of Helsinki.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Institutional Affiliation Statement
All authors are affiliated with Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, India, where the clinical work and research were conducted.
Third-party Writing/Editing Assistance
None.